$27.40
-2.62-8.73%
At close: -
$28.51
1.114.05%
After Hours: 4:18 PM EDT
Comments
Loading...
Latest news for Structure Therapeutics (NASDAQ:GPCR) Stock
Structure Therapeutics Stock (NASDAQ: GPCR)
Categories: All
Wednesday, January 08, 2025
Monday, January 06, 2025
Thursday, December 19, 2024
Wednesday, December 18, 2024
Tuesday, December 17, 2024
Wednesday, December 04, 2024
Wednesday, November 13, 2024
Wednesday, October 23, 2024
Wednesday, October 16, 2024
Monday, September 30, 2024
Monday, September 23, 2024
Monday, September 16, 2024
Monday, September 09, 2024
Monday, August 19, 2024
Thursday, August 15, 2024
Friday, August 09, 2024
Thursday, August 08, 2024
Thursday, July 18, 2024
Wednesday, July 17, 2024
- Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Structure Therapeutics shares are trading low...
- Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
- ASML Reports Q2 Results, Joins Spirit Airlines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Monday, July 15, 2024
Monday, July 01, 2024
Thursday, June 20, 2024
Monday, June 17, 2024
Friday, June 07, 2024
Thursday, June 06, 2024
Monday, June 03, 2024
- Structure Therapeutics Files Registration Sta...
- Structure Therapeutics Obesity Candidate Is 'Very Competitive' To Eli Lilly's Orforglipron, Analyst Says
- Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- 10 Health Care Stocks With Whale Alerts In Today's Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Structure Therapeutics shares are trading hig...
- Obesity Data From Structure Therapeutics Shows Potential For Weight Loss Drug Candidate
- Cantor Fitzgerald Reiterates Overweight on St...
- Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Structure Therapeutics Reports 12-Week Result...